Levetiracetam: Difference between revisions
From SEHK Wiki
Created page with "Category: Drugs Category: Seizures '''Levetiracetam''' (中文: 左乙拉西坦)is an anticonvulsant medication used to treat epilepsy. It is taken either by mouth..." |
No edit summary |
||
| Line 17: | Line 17: | ||
|LEVE05 | |LEVE05 | ||
| | | | ||
|} | |||
==Mechanism of Action== | |||
Anticonvulsant medication. It inhibits presynaptic calcium channels, reducing neurotransmitter release. This is believed to impede impulse conduction across synapses. | |||
==Dosage== | |||
{|class="wikitable" | |||
!style="text-align: left"| Monotherapy of focal seizures | |||
|''By mouth, or by intravenous infusion | |||
ADULT and CHILD over 16 years: | |||
*Initially 250 mg once daily increased after 1-2 weeks to 250 mg twice daily; thereafter | |||
*Increased according to response in steps of 250 mg twice daily every 2 weeks | |||
*Max. 1.5 g twice daily | |||
|- | |||
!style="text-align: left"| Adjunctive therapy of focal seizures | |||
|''By mouth | |||
CHILD 1-5 months | |||
*Initially 7 mg/kg once daily, then | |||
*Increased in steps of up to 7 mg/kg twice daily every 2 weeks | |||
*Max. per dose 21 mg/kg twice daily | |||
CHILD 6 months – 17 years (body-weight up to 50 kg): | |||
*Initially 10 mg/kg once daily, then | |||
*Increased in steps of up to 10 mg/kg twice daily every 2 weeks | |||
*Max. per dose 30 mg/kg twice daily | |||
CHILD 12-17 years (body-weight 50 kg and above): | |||
*Initially 250 mg twice daily, then | |||
*Increased in steps of 500 mg twice daily every 2-4 weeks | |||
*Max. per dose 1.5 g twice daily | |||
ADULT: | |||
*Initially 250 mg twice daily, then | |||
*Increased in steps of 500 mg twice daily increased every 2-4 weeks | |||
*Max. per dose 1.5 g twice daily | |||
|''By intravenous infusion | |||
CHILD 4-17 years (body-weight up to 50 kg): | |||
*Initially 10 mg.kg once daily, then increased in steps of up to 10 mg/kg twice daily every 2 weeks | |||
*Max. per dose 30 mg/kg twice daily | |||
CHILD 12-17 years (body-weight 50 kg and above): | |||
*Initially 250 mg twice daily, then | |||
*Increased in steps of 500 mg twice daily every 2 weeks | |||
*Max. per dose 1.5 g twice daily | |||
ADULT: | |||
*Initially 250 mg twice daily, then | |||
*Increased in steps of 500 mg twice daily every 2-4 weeks | |||
*Max. per dose 1.5 g twice daily | |||
!style="text-align: left"| Adjunctive therapy of myoclonic seizures and tonic-clonic seizures | |||
|''By mouth, or by intravenous infusion | |||
CHILD 12-17 years (body-weight up to 50 kg): | |||
*Initially 10 mg/kg once daily, then | |||
*Increased in steps of up to 10 mg/kg twice daily every 2 weeks | |||
*Max. per dose 30 mg/kg twice daily | |||
CHILD 12-17 years (body-weight 50 kg or above): | |||
*Initially 250 mg twice daily, then | |||
*Increased in steps of 500 mg twice daily every 2 weeks | |||
*Max. per dose 1.5 g twice daily | |||
ADULT: | |||
*Initially 250 mg twice daily, then | |||
*Increased in steps of 500 mg twice daily every 2-4 weeks | |||
*Max. per dose 1.5 g twice daily | |||
|} | |} | ||
Revision as of 22:57, 8 October 2020
Levetiracetam (中文: 左乙拉西坦)is an anticonvulsant medication used to treat epilepsy. It is taken either by mouth as an immediate or extended release formulation or by injection into a vein.
Pronunciation
Drug Names
| Generic Name 藥名 | HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Levetiracetam tablet 500mg | LEVE01 | P1S1S3 |
| Levetriacetam infusion 100mg/ml 5 ml | LEVE05 |
Mechanism of Action
Anticonvulsant medication. It inhibits presynaptic calcium channels, reducing neurotransmitter release. This is believed to impede impulse conduction across synapses.
Dosage
| Monotherapy of focal seizures | By mouth, or by intravenous infusion
ADULT and CHILD over 16 years:
| |||
|---|---|---|---|---|
| Adjunctive therapy of focal seizures | By mouth
CHILD 1-5 months
CHILD 6 months – 17 years (body-weight up to 50 kg):
CHILD 12-17 years (body-weight 50 kg and above):
ADULT:
|
By intravenous infusion
CHILD 4-17 years (body-weight up to 50 kg):
CHILD 12-17 years (body-weight 50 kg and above):
ADULT:
|
Adjunctive therapy of myoclonic seizures and tonic-clonic seizures | By mouth, or by intravenous infusion
CHILD 12-17 years (body-weight up to 50 kg):
CHILD 12-17 years (body-weight 50 kg or above):
ADULT:
|
